SPONSOR
Zulfa Omer
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: CLL/SLLCLLSLLChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaSmall Lymphocytic Lymphoma VariantChronic Lymphocytic Leukemia Variants
Zulfa Omer is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zulfa Omer
How many clinical trials has Zulfa Omer sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Zulfa Omer, of which 1 are actively recruiting participants. These trials cover conditions including CLL/SLL, CLL, SLL. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zulfa Omer research focus on?
Zulfa Omer clinical trials span CLL/SLL, CLL, SLL, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zulfa Omer clinical trial?
To participate in a Zulfa Omer trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zulfa Omer trials with current recruitment status updated daily.
Clinical Trials by Zulfa Omer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology